These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6468828)

  • 1. [Use of cofosfolactamine in localized bacterial infections].
    Scalzini A; Chiodera A; Sueri L
    G Ital Chemioter; 1984; 31(1-2):205-6. PubMed ID: 6468828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update on antibiotic therapy. 15) A combination of fosfomycin and amoxicillin (penamic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 Mar; 74(13):769-74. PubMed ID: 6835564
    [No Abstract]   [Full Text] [Related]  

  • 3. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
    Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
    Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial.
    Novelli A; Rizzo M; Buzzoni P; Coronnello M; Alunno Pergentini S; Giganti E; Periti P
    Chemioterapia; 1984 Oct; 3(5):281-5. PubMed ID: 6398125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin in the treatment of some infectious diseases].
    Aceti A; Vullo V; Ferone U; Delia S
    Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of Augmentin and co-trimoxazole in the treatment of adult infections in general practice.
    Davies JG; Rose AJ; Walker GD
    Br J Clin Pract; 1982 Dec; 36(11-12):387-93, 403. PubMed ID: 6984654
    [No Abstract]   [Full Text] [Related]  

  • 7. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and bacteriological evaluation of Augmentin: a new broad spectrum antibiotic in general practice.
    Hansrod D; Howalder R; Rozar GJ
    East Afr Med J; 1983 Nov; 60(11):778-82. PubMed ID: 6368188
    [No Abstract]   [Full Text] [Related]  

  • 11. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fosfomycin in severe infection in neonatology].
    Rossignol S; Regnier C
    Ann Pediatr (Paris); 1984 May; 31(5):437-44. PubMed ID: 6742722
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentin therapy in the treatment of urinary tract infections in general practice.
    Abbas AM; Goel PK; Venkit N; Gowers E
    Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study and use of fosfomycin in the clinical field].
    Azzaroli P; de Martinis E; Zoli F; Garoia C
    G Ital Chemioter; 1978; 25(1):1-4. PubMed ID: 376386
    [No Abstract]   [Full Text] [Related]  

  • 16. Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?
    Hepping N; Simon A
    Int J Antimicrob Agents; 2009 Apr; 33(4):389. PubMed ID: 19097756
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Clin Pract; 1984 May; 38(5):188-9. PubMed ID: 6610437
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fosfomycin. II. Antimicrobial activity in vivo].
    Carlone NA; Cuffini AM; Savoia D
    G Batteriol Virol Immunol; 1977; 70(7-12):215-25. PubMed ID: 615746
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nephrological experiences in the treatment of urinary infections by fosfomycin].
    Mioli V; Figus S
    Minerva Med; 1978 Dec; 69(59):4093-6. PubMed ID: 740305
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical study of imipenem/cilastatin in the treatment of generalized and localized infections.
    Tigano F; D'Ambrosio FP; Angio LG
    J Chemother; 1989 Jul; 1(4 Suppl):638-40. PubMed ID: 16312569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.